which glp-1 drugs are approved for obesity U.S. Rate Drops As Usage Grows Upcoming wave of hormone-based therapies

While some of these still have merit, they often fail to deliver long-term, sustainable success

Awareness is powerful, but a core challenge in lifestyle change is the human tendency to prioritize immediate comfort over future health what behavioral economists call present bias

Mochi Health has a BBB pattern-of-complaints alert, posted in April 2025, covering complaints about consumers not receiving their medications, being left on hold, and unanswered messages

"We say that GLP-1s are training wheels

Circulation 129(5):587597 van Bommel EJ, Muskiet MH, van Baar MJ, Tonneijck L, Smits MM, Emanuel AL et al (2019) The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial

In 1959, the innovation of radioimmunoassay by Berson and Yalow helped quantify insulin secretion in humans [9]